DeCEDA/Qrius 2022 was a milestone year for India. India walked into 2022 with an infectious wave of Covid-19 impacting lakhs of people, the wave receded a few weeks into the year. As hopes for a post-pandemic recovery surged, war in Ukraine brought in new challenges for the economy. With supply chains disrupted, global sanctions imposed on Russia, prices of fuel and food shot up. Inflation, already on a high from pent-up...
More »SEARCH RESULT
Realistic analysis shows that the Indian economy has simply taken little steps in Q1 instead of a quantum leap
There is euphoria abound about India's growth performance during the first quarter of the current fiscal. As compared to the corresponding period last year, the year-on-year (y-o-y) GDP growth in the first quarter (Q1) of 2022-23 is down. However, one should take into account the fact that the high growth performance of the real GDP in Q1 of 2021-22 was due to the low base in the corresponding period of...
More »Are we choosing the right solutions for reducing GHG emissions from the transport sector?
The transport sector is important for the smooth functioning of an economy. The supply chains for various products and by-products (both domestically as well as internationally) can work efficiently only if the transportation of raw materials and inputs, and final goods and commodities takes place without disruption. Due to economic growth, India’s annual CO2 (i.e., carbon dioxide) emission has expanded from 1.19 billion tonnes in 2005 to 2.44 billion tonnes...
More »Is the govt. doing enough for the Jan Aushadhi scheme?
On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »India risks being edged out of patent waiver plan at WTO -Jacob Koshy and Suhasini Haidar
-The Hindu Negotiations are at a “critical and sensitive” stage in Geneva, say sources India runs the risk of being excluded from a proposal it co-authored at the World Trade Organisation (WTO) negotiations, in 2020, to “temporarily waive” intellectual property rights (IPR) held, by primarily Western countries, on vaccines, therapeutics and diagnostics for covid-19. Geneva Health Files, a Switzerland-based newsletter portal that tracks developments in intellectual property, first reported on Friday that “a...
More »